What organisations, clinicians, iwi, Māori health providers, or other stakeholders, if any, were consulted by Pharmac regarding the proposal to remove Māori and Pacific priority access to Type 2 diabetes medicines?

Answer

I am advised that Pharmac engaged with a range of groups to advise and discuss the current proposal to widen access to Type 2 diabetes medicines. The groups are: •Consumer Advisory Group (CAC) •Obesity Treatments Advisory Group (OTAG) • Diabetes Advisory Committee •Obesity Treatments Advisory Committee •Nephrology Advisory Committee •Cardiovascular Advisory Committee •PTAC •Health NZ Cardiac Network •National Renal Network •Diabetes Foundation NZ •Aotearoa Diabetes Collective •Diabetes Wellington •New Zealand Society for the Study of Diabetes (NZSSD) •Māori stakeholders: Te ORA (Māori Medical Association) •Ngā Pou Mana (Māori Allied Health) •Māori Pharmacists Association •Māori Clinicians Group •Māori Nurses Association, Research Group.